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Abstract
Background: It has become increasingly evident that the immune and nervous systems are closely intertwined, relying
on one another during regular homeostatic conditions. Prolonged states of imbalance between neural and immune
homeostasis, such as chronic neuroinflammation, are associated with a higher risk for neural damage. Toxoplasma gondii
is a highly successful neurotropic parasite causing persistent subclinical neuroinflammation, which is associated with
psychiatric and neurodegenerative disorders. Little is known, however, by what means neuroinflammation and the
associated neural impairment can be modulated by peripheral inflammatory processes.
Methods: Expression of immune and synapse-associated genes was assessed via quantitative real-time PCR to
investigate how T. gondii infection-induced chronic neuroinflammation and associated neuronal alterations can
be reshaped by a subsequent acute intestinal nematode co-infection. Immune cell subsets were characterized
via flow cytometry in the brain of infected mice. Sulfadiazine and interferon-γ-neutralizing antibody were
applied to subdue neuroinflammation.
Results: Neuroinflammation induced by T. gondii infection of mice was associated with increased microglia activation,
recruitment of immune cells into the brain exhibiting Th1 effector functions, and enhanced production of Th1 and pro-
inflammatory molecules (IFN-γ, iNOS, IL-12, TNF, IL-6, and IL-1β) following co-infection with Heligmosomoides polygyrus.
The accelerated cerebral Th1 immune response resulted in enhanced T. gondii removal but exacerbated the
inflammation-related decrease of synapse-associated gene expression. Synaptic proteins EAAT2 and GABAAα1, which are
involved in the excitation/inhibition balance in the CNS, were affected in particular. These synaptic alterations were
partially recovered by reducing neuroinflammation indirectly via antiparasitic treatment and especially by application of
IFN-γ-neutralizing antibody. Impaired iNOS expression following IFN-γ neutralization directly affected EAAT2 and GABAAα1
signaling, thus contributing to the microglial regulation of neurons. Besides, reduced CD36, TREM2, and C1qa gene
expression points toward inflammation induced synaptic pruning as a fundamental mechanism.
Conclusion: Our results suggest that neuroimmune responses following chronic T. gondii infection can be modulated by
acute enteric nematode co-infection. While consecutive co-infection promotes parasite elimination in the CNS, it also
adversely affects gene expression of synaptic proteins, via an IFN-γ-dependent manner.
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Background
Immune activity in the central nervous system
(CNS) historically has been thought to almost invari-
ably reflect pathological processes [1–3]. However,
inflammation is an integral component of neurobio-
logical processes supporting tissue repair, synaptic
pruning, pathogen removal, and inflammation reso-
lution to maintain homeostasis [4]. Still, there is the
physical segregation of the nervous and immune sys-
tems via the blood-brain barrier (BBB), separating
the CNS from the peripheral cytokine milieu and al-
lows for more controlled neuro-immune activity.
However, when the BBB is compromised, as in neu-
roinflammation, the brain parenchyma becomes
threatened as there is an increased activation of both
resident and recruited immune activity [5]. Inter-
feron-γ (IFN-γ), a crucial type 1 cytokine, for ex-
ample, has been shown to modulate the activity of
the principal inhibitory neurotransmitter gamma-
aminobutyric acid (GABA), thereby affecting
neuronal connectivity and social behavior [6]. Pro-in-
flammatory cytokines such as tumor necrosis factor
(TNF), interleukin (IL)-6, or IL-1β have been linked
to neuronal cell death via both apoptosis and necro-
sis and to cognitive and motor dysfunction [7, 8].
Furthermore, downregulation of pro-inflammatory
myeloid cell activity via the type 2 cytokine IL-4
produced by T cells has been associated with in-
creased release of brain-derived neurotrophic factor
(BDNF) and reversal of memory impairment [9].
Conversely, microglia, the resident innate immune
cells of the CNS, have been shown to express recep-
tors for multiple neurotransmitters including GABA,
glutamate, or dopamine [10–13]. These findings
highlight a rather pleiotropic role of the respective
proteins in normal physiology, with their functions
depending on their location. In chronic neuroinflam-
mation, there is a prolonged activated and recruited
immune presence in the CNS and neural and im-
mune functions can become dysbalanced, increasing
the risk for secondary neural damage. This is evident
in the strong association of chronic neuroinflamma-
tion with neurodegenerative diseases such as Alzhei-
mer’s disease (AD) [14], Parkinson’s disease (PD)
[15], amyotropic lateral sclerosis (ALS) [16], and the
profound inflammation-related neural damage found
in multiple sclerosis (MS) [17].
Invasion of the CNS by neurotropic pathogens is a
common cause of chronic neuroinflammation [18].
Toxoplasma gondii (T. gondii) preferentially infects
neurons where it forms cysts that remain for the
lifetime of the host causing persistent subclinical
neuroinflammation [19, 20]. The conversion of fast-
replicating tachyzoites to slow-replicating bradyzoites
and the subsequent formation of a cyst wall are in-
duced by the host’s adaptive immune response. T
cells are critical in preventing the reactivation of
bradyzoite-filled cysts, as evident in the prolonged
low-grade cerebral inflammation to control chronic
infection seen in immunocompetent hosts [21, 22].
Neuroinflammation is initially facilitated when resi-
dent microglia and astrocytes first encounter the
invading parasites, which leads to the release of che-
mokines and pro-inflammatory mediators (i.e., TNF,
IL-6, or IL-1β) followed by recruitment of peripheral
myeloid and lymphoid cells [23–25]. Myeloid cells
support chronic neuroinflammation by their capacity
to produce pro-inflammatory cytokines such as IL-
12, which is crucial in maintaining the production of
IFN-γ. Produced primarily by CD4+ and CD8+ T
cells as well as innate lymphoid cells [26, 27], IFN-γ
is an essential factor in host protection against the
parasite, as it triggers multiple immune cell mecha-
nisms leading to the elimination of the parasite [28].
Moreover, IFN-γ can activate the choroid plexus
endothelium, thereby aiding the migration of leuko-
cytes into the CNS parenchyma [29, 30].
T. gondii infection has been shown to alter behavior in
rodents [29], and in humans, seropositive individuals have
been shown to exhibit subclinical behavioral alterations as
well as an increased risk for neuropsychiatric disorders
[30] such as PD [31], AD [32], or schizophrenia [33]. Con-
clusively, a recent large-scale study provided compelling
evidence for the association between latent T. gondii infec-
tion and schizophrenia in humans [18]. Distinctly, the im-
mune response to T. gondii and the neuropathological
mechanisms of these disorders overlap by involving the
same cell types and, at least in part, the same molecules.
We have previously demonstrated that chronic T.
gondii infection leads to a loss of structural com-
plexity of axons and dendrites, primarily in the neo-
cortex and hippocampus [34]. Moreover, we have
recently shown that the synaptic protein composition
was altered, in particular, with a downregulation of
components of glutamatergic signaling as a conse-
quence of the inflammatory milieu induced by
chronic infection [35].
A common clinical approach for treating neuroinflamma-
tory disorders has been the application of
immunosuppressive or anti-inflammatory drugs, to slow
down disease progression, but side effects are often severe
[36, 37]. In the case of infections underlying neuroinflam-
mation, as in cerebral toxoplasmosis, this is particularly
dangerous as immunocompromised individuals are at risk
for reactivation of life-threatening acute Toxoplasma en-
cephalitis (TE) [38, 39]. More recently, immunomodulatory
approaches are being applied to modify the immune re-
sponse without removing the homeostatic functions of cells
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such as tissue maintenance and repair [40–42]. Helminths
administered as immunotherapy have gained significant at-
tention, where live parasitic worms or worm-derived mole-
cules are applied as treatment of chronic inflammatory
diseases [43–45]. By taking advantage of helminths’ natural
abilities to create an anti-inflammatory environment, hel-
minth infection and helminth-derived molecules have the
potential to beneficially modulate immune responses to po-
tentially pre-existing diseases. Helminth immunomodula-
tion has already shown success in human models of
inflammatory bowel diseases [46, 47] and multiple sclerosis
(MS) [48–50] as well as murine models of allergic airway
hyperreactivity [51–53] rheumatoid arthritis (RA), type 1
diabetes, and experimental autoimmune encephalomyelitis
(EAE) [44, 54, 55]. Helminths primarily achieve this immu-
nomodulation via induction of regulatory circuits. In gen-
eral, helminth infections stimulate the release of IL-4, IL-5,
IL-10, and IL-13, which shifts T cell responses towards a
Th2 response [56]. Regulatory T cells (Tregs) as well as
regulatory macrophages are also stimulated, leading to in-
creased production of anti-inflammatory cytokines IL-10
and transforming growth factor beta (TGF-β), which cor-
roborate the helminths’ induced anti-inflammatory envir-
onment [57]. Scientific interest continues to grow around
helminth-dependent immune modulation, especially in re-
sponse to the increasing incidence of allergies and auto-im-
mune diseases [58, 59]. However, there is insufficient
knowledge about the potential effects of peripheral hel-
minth infections on concurrent inflammatory processes in
the CNS.
In the present study, we aimed to elucidate how im-
munological and neural sequelae of T. gondii-induced neu-
roinflammation are altered by a concomitant intestinal
helminth infection and resulting immunomodulation. To
this end, we administered the strictly enteric intestinal
nematode Heligmosomoides polygyrus (H. polygyrus) to
mice previously infected with T. gondii. H. polygyrus infec-
tion is known to lead to a strong induction and systemic
dissemination of Th2-type responses during the acute
phase of infection [60, 61]. Our data revealed that a co-in-
fection of T. gondii-infected mice with H. polygyrus
induced an increase of the recruitment of Ly6Chi inflamma-
tory monocytes and subsequent increase in the Th1
immune response of resident and recruited immune cells,
characterized by IFN-γ, IL-12, iNOS, and MHC II expres-
sion. This upregulation of the Th1 response and inflamma-
tory cell recruitment ultimately led to a significant
reduction of the parasite burden in co-infected mice. How-
ever, this was accompanied by a reduction in neural
markers, as determined by synaptic gene expression
changes. Notably, the synaptic alterations were partially re-
covered by limiting infection, and thus neuroinflammation
with sulfadiazine, or by application of IFN-γ-neutralizing
antibodies. IFN-γ-dependent synaptic pruning might be




Experiments were conducted using female, wild type
(WT) C57BL/6 mice (8 weeks old; purchased from
Janvier Laboratories, Cedex, France) bred under spe-
cific pathogen-free (SPF) conditions. All mice were
group-housed in 12-h day/night cycles at 22 °C with
free access to food and water. All animal experiments
were approved by local authorities according to
German and European legislation.
Toxoplasma gondii infection
T. gondii cysts of type II strain ME49 were harvested
from the brains of female NMRI mice infected with T.
gondii cysts 8–12months earlier, as described previously
[34]. In short, isolated brains were mechanically homog-
enized in 1-ml sterile phosphate-buffered saline (PBS),
and the number of cysts in the homogenate was deter-
mined using a light microscope. Mice were infected with
two cysts via oral gavage (concentration adjusted to 2
cysts per 200 μl).
Heligmosomoides polygyrus infection
H. polygyrus was retained by serial passage in C57BL/6Rj
mice as previously described [62]. Mice were infected by
oral gavage with 200 L3 larvae in 200 μl PBS.
Worm fecundity and worm burden
Adult worms were isolated from the small intestine and
counted. Female worms were subsequently kept indi-
vidually (8 per mouse) in a 96-well round-bottom plate
containing RPMI, 200 U/ml penicillin, and 200 μg/ml
streptomycin (all from PAA, Austria) at 37 °C. After 24
h, female H. polygyrus adults were removed from the
wells and fecundity was determined by counting the eggs
shed per female worm using a binocular microscope.
Sulfadiazine treatment
A solution of 400 mg/L of sulfadiazine in drinking water
was prepared and then autoclaved [63]. Mice received
sulfadiazine treatment in their drinking water ad libitum.
Treatment began on day 10 post-infection and contin-
ued until sacrifice on day 28 post-infection.
IFN-γ neutralization
IFN-γ was neutralized by administration of monoclonal
antibody against IFN-γ (clone: XMG1.2, DRFZ, Berlin).
Mice were treated intraperitoneally (i.p.) with 0.5 mg
anti-IFN-γ in 200 μl PBS on days 14, 17, 20, 23, and 26
post-infection [64]. Isotype IgG1 antibody (clone: 19e1,
DRFZ, Berlin) was used as control. Saline injections
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were administered to non-infected and H. polygyrus-
only-infected mice to control for the antibody treatment.
Organ collection
First, mice were deeply anesthetized by isoflurane inhal-
ation (Baxter). Subsequently, mice were transcardially
perfused with sterile ice-cold PBS. Brains were removed
and stored in RPMI medium (Life Technologies) or
RNAlater (Qiagen) for additional analysis. Samples were
stored in RNAlater (Qiagen), were kept at 4 °C over-
night, and then transferred to − 20 °C. Samples in RPMI
medium were stored on ice until further experimental
procedures.
Cell isolation
To isolate brain immune cells, brains were homogenized
in a buffer containing 1M HEPES (pH 7.3) and 45%
glucose and then filtered through a 70-μm strainer. Leu-
kocytes were separated via Percoll gradient centrifugation
(GE Healthcare) as described previously [65].
Flow cytometric analysis
Single-cell suspensions were incubated with an anti-
FcγIII/II receptor antibody (clone 93, eBioscience) to
block unspecific binding and Zombie NIR™ (Biolegend),
a fixable viability dye. Thereafter, cells were stained with
fluorochrome-conjugated antibodies against cell surface
markers: CD45 (30-F11), CD11b (M1/70), Ly6C
(HK1.4), MHCI (28-14-8), and MHCII (M5/114.15.2) all
purchased from eBioscience; CD3 (17A2), CD4 (RM4-5),
and CD8α (53-6.7) all purchased from Biolegend; and
Ly6G (1A8) purchased from BD Biosciences in FACS
buffer at 4 °C for 30 min and then fixed in 4% parafor-
maldehyde (PFA, Affymetrix). Matched FMO controls
were used to assess the level of background fluorescence
in the respective detection channel.
Intracellular staining was performed as previously de-
scribed [66]. Afterwards, cells were incubated with anti-
FcγIII/II receptor antibody (clone 93, eBioscience) and
Zombie NIR™ (Biolegend). Surface epitopes were then
stained with CD45 (30-F11), CD11b (M1/70), Ly6C
(HK1.4), Ly6G (1A8), CD3 (17A2), CD4 (RM4-5), and
CD8α (53-6.7). To measure cytokine expression, cells
were stained with TNF (MP6-XT22), IL-12p40 (C17.8),
IL-10 (JES5-16ES), purchased from eBioscience; iNOS
(6, BD Biosciences); and IFN-γ (XMG1.2, Biolegend).
Matched isotype controls were used to assess the level
of non-specific binding.
Flow cytometric analysis was performed on BD FACS
CANTO II (BD Bioscience) and on Attune NxT Flow
Cytometer (Thermo Fisher) and analyzed with FlowJo
(version 10, Tree star).
DNA and RNA isolation
Samples stored in RNAlater were homogenized in
BashingBeads tubes (Zymo Research, Freiburg,
Germany). AllPrep DNA/RNA Mini Kit (Qiagen) was
used to isolate DNA, and the peqGOLD total RNA kit
(Peqlab, Erlangen, Germany) was used to isolate total
RNA from the homogenate following the manufacturer’s
instructions, respectively.
Semiquantitative PCR and RT-qPCR
T. gondii burden was determined using the FastStart Es-
sential DNA Green Master kit (Roche). The target T.
gondii gene used was TgB1, and Mm. Asl (TIBMolbiol,
Berlin, Germany) was used as a reference. The stage of
parasite burden was quantified using the Power SYBR®
Green RNA-to-CT™ 1-Step Kit (Thermo Fisher) for bra-
dyzoite-specific Bag1 and tachyzoite-specific Sag1 using
Gapdh as reference gene. All genes were purchased from
TIBMolbiol, Berlin, Germany.
Relative gene expression was determined similar to
previous descriptions [67, 68] using the TaqMan® RNA-
to-CT™ 1-Step Kit (Life Technologies). TaqMan® Gene
Expression Assays (Life Technologies) were used for
mRNA amplification of Ifn-γ (Mm00801778_m1), Il10
(Mm00439616_m1), Tnf (Mm00443258_m1), Il1b
(Mm00434228_m1), Il12a (Mm00434165_m1), Arg1
(Mm00475988_m1), Il6 (Mm00446190_m1), Il13
(Mm00434204_m1), Il4 (Mm0445259_m1), Nos2
(Mm00440485_m1), Trem2 (Mm04209422_m1), Bdnf
(Mm04230607_s1), Syp (Mm00436850_m1), Dlg4
(Mm00492193_m1), Slc1a2 (Mm01275814_m1), Gabra1
(Mm00439046_m1), and C1qa (Mm00432142_m1). Ex-
pression of Hprt (Mm01545399_m1) was chosen as ref-
erence, and target/reference ratios were calculated with
the LightCycler® 96 software version 1.1 (Roche). All re-
sults were further normalized to the mean of the corre-
sponding non-infected control group.
Statistical analysis
Data sets were statistically analyzed using SPSS 22.0
(IBM, Armonk, NY). To account for the factorial na-
ture of our experiments and the multiple measures of
outcome, we computed ANOVA models with infec-
tion status and or treatment as between-subjects fac-
tors and different outcome measures (e.g., cell counts,
gene expression) as within-subject factors or
dependent variables. Whenever we could assume a
positive correlation between outcome measures,
ANOVAs for repeated measures were employed, and
otherwise, MANOVAs were used. When data from
different series of experiments or different PCR plates
were analyzed in the same statistical model, appropri-
ate covariates were included. Whenever a within-sub-
jects factor had more than two levels, degrees of
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freedom were corrected for non-sphericity using the
Greenhouse-Geisser correction. ANOVAs with signifi-
cant effects of interest were followed by planned t
test comparisons to assess directionality of the ob-
served effects. Owing to the small sample sizes,
unequal variances were assumed in all t tests. The
significance level was set to p < .05 for all statistical
comparisons, and two-tailed p values are reported for
all t tests unless otherwise stated.
Diagrams were generated using GraphPad Prism 6.0
(GraphPad Software). Data are presented as mean ±
SEM.
Results
H. polygyrus co-infection amplifies the Th1 response to
T. gondii in the brain
On day 14 post T. gondii infection, after the parasites
had crossed the blood-brain barrier (BBB) and provoked
a CNS immune response, mice were co-infected with H.
polygyrus. Immune cell collection took place on day 28,
thus 14 days post H. polygyrus infection and during the
acute phase of the helminth infection (Fig. 1a). To deter-
mine whether an acute intestinal helminth infection af-
fects T. gondii-dependent neuroinflammation, we used
qRT-PCR to examine changes in cytokine gene expres-
sion levels in whole-brain homogenates (Fig. 1b–k).
Gene expression analysis of the pro-inflammatory cyto-
kines IFN-γ, TNF, and IL-12, which have previously been
implicated in the immune response to T. gondii [69, 70],
showed significant effects of both T. gondii (F1,14 =
311.85, p < 0.001; three-way ANOVA for repeated
measures with cytokine as within-subjects factor and T.
gondii and H. polygyrus as between-subjects factors) and
H. polygyrus (F1, 14 = 11.55, p = 0.004) infection, as well
as an interaction of the two pathogens (F1, 14 = 10.77,
p = 0.005). We further observed interactions of both
pathogens and their combination with cytokine, reflect-
ing differential effects on IFN-γ, TNF, and IL-12 (all F >
8.40, all p < 0.010). Specifically, co-infected mice com-
pared to mice infected with T. gondii only showed
significantly higher expression of IFN-γ (post hoc two-
Fig. 1 Type 1 immune response in the brain increased upon co-infection with H. polygyrus. a Experimental setup: C57BL/6 mice were first
infected p.o. with T. gondii (2 cysts, ME49). On day 14 p.i., mice were infected p.o. with H. polygyrus (200 L3 larvae). b–k qRT-PCR data for relative
expression of mRNA in whole brain homogenate from non-infected (Non.Inf.), T. gondii-infected (Tg), T. gondii and H. polygyrus co-infected
(Tg+Hp), and H. polygyrus-infected (Hp) mice. Relative mRNA levels were normalized to the mean of the non-infected control group (Non.Inf).
Bars represent mean ± SEM
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sample t test: t7.4 = 3.51, p = 0.009) and TNF (t7.7 = 2.74,
p = 0.026), while the difference in IL-12 expression was
not significant (p = 0.591) (Fig. 1b–d). H. polygyrus-in-
fected mice compared to uninfected mice, on the other
hand, exhibited significantly increased expression of
TNF (t6.9 = 2.82, p = 0.026), but not IFN-γ or IL-12 (all
p > 0.238).
When testing for expression changes of IL-4, IL-10,
and IL-13 as mediators of the Th2 or anti-inflamma-
tory responses, we found a significant main effect of
T. gondii infection (F1, 12 = 206.22, p < 0.001; three-
way ANOVA for repeated measures with cytokine as
within-subjects factor and T. gondii and H. polygyrus
as between-subjects factors) as well as a cytokine by
T. gondii interaction (F1.0, 12.2 = 147.70, p < 0.001), but
no effects related to H. polygyrus infection alone or
in interaction with T. gondii interaction (all p > 0.187)
(Fig. 1e–g). Together with the additive effects of T.
gondii and H. polygyrus on IFN-γ and TNF expres-
sion, these results suggest that a co-infection with the
enteric nematode H. polygyrus during the acute phase
of the helminth infection shifts the balance of Th1/
Th2 responses towards an increased Th1-type cyto-
kine response.
In an exploratory analysis, we further assessed the
effects of T. gondii and H. polygyrus infection on
several additional markers previously implicated in
the immune responses to T. gondii infection (Arg1,
IL-6, IL-1β, and iNOS; Fig. 1h–k; see [71]), revealing
effects of both T. gondii (three-way ANOVA for re-
peated measures with gene as within-subjects factor
and T. gondii and H. polygyrus infection as between-
subjects factors: F1, 12 = 145.05, p < 0.001) and H.
polygyrus (F1, 12 = 7.10, p = 0.021) as well as an inter-
action (F1, 12 = 7.13, p = 0.020). The observed inter-
action was driven by increased expression of IL-1β
(t5.9 = 2.29, p = 0.033, one-tailed), IL-6 (t6.8 = 2.33, p =
0.027, one-tailed), and iNOS (t4.1 = 2.41, p = 0.036,
one-tailed) in co-infected animals compared to ani-
mals infected with T. gondii only, whereas no single
marker showed a significant difference between un-
infected mice and mice infected with H. polygyrus
only (all one-tailed p > 0.155).
Given the more pronounced clearance of T. gondii and
lack of a Th2 response in co-infected mice, we investi-
gated the immune response to H. polygyrus. To this end,
we examined the gene expression of Th2 cytokines IL-4
and IL-13 (characteristic of H. polygyrus infection) in the
spleens of mice (Additional file 1: Figure S1A-B). There
was a pronounced interactive effect of the parasites on
cytokine infection (F1, 14 = 308.30, p < 0.001; three-way
ANOVA for repeated measures with cytokine as within-
subjects factor and T. gondii and H. polygyrus as be-
tween-subjects factors), reflecting the significantly higher
expression of both IL-4 and IL-13 in mice infected with
H. polygyrus only compared to all other groups (all t >
11.93, all p < 0.001). Furthermore, both mice infected
with T. gondii alone and co-infected animals showed
lower splenic expression of IL-4 and IL-13 compared to
uninfected mice (all t > 8.76, all p < 0.002). From these
data, we concluded that mice were capable of manifest-
ing an immune response to H. polygyrus, but that their
immune response was shifted from a Th2- to Th1-type
response when T. gondii infection was present.
Altered immune response results in reduced parasite
burden in the brain
To investigate if the immune response reflected by
the increase in T. gondii-related cytokines influenced
the overall parasite burden, we measured DNA levels
of T. gondii-specific gene TgB1 in the brains of in-
fected animals. TgB1 DNA levels were significantly
decreased in co-infected animals compared to mice
infected with T. gondii only (t7.9 = 3.24, p = 0.012;
Fig. 2a). Expression analysis of stage-specific genes for
tachyzoites (Tgsag1) and bradyzoites (Tgbag1) further
showed that the decreased parasite burden was largely
attributable to fast-replicating, highly virulent tachy-
zoites (t7.5 = 2.86, p = 0.022; Fig. 2b), while the burden
of less virulent, slow-replicating bradyzoites did not
change significantly (t7.4 = 0.83, p = 0.433; Fig. 2c).
These results suggest that the increased Th1 response
in co-infected mice actually increased the effective-
ness of T. gondii elimination.
In accordance with these results, we next investi-
gated how the co-infection affected the ability to
control the H. polygyrus infection. To this end, we
examined worm burden and worm fecundity from
co-infected compared to H. polygyrus-only infected
animals (Fig. 2d–e). We observed no significant
change in worm burden (F1, 20 = 0.02, p = 0.889;
ANCOVA with infection status as fixed factor and
experiment as covariate). Regarding worm fecundity
in co-infected animals compared to mice infected
with H. polygyrus alone, we observed nominally
lower egg counts in co-infected animals, although
this did not reach significance when testing conser-
vatively (ANCOVA with average egg count per
mouse as dependent variable, infection status as
fixed factor, and standard deviation of egg count and
number of worms counted as covariates: F1, 6 = 2.46,
p = 0.168). When directly comparing the number of
eggs per worm as a function of infection status, the
average number of eggs was indeed significantly
higher in co-infected mice (t60.3 = 3.28, p = 0.002),
suggesting a (minor) detrimental effect of T. gondii
infection on helminth elimination.
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Acute H. polygyrus co-infection amplifies Th1 response of
brain recruited and resident immune cells
To characterize the cellular composition and uncover the
origin of the cytokines responsible for the inflammatory
response to the parasites, we analyzed the immune cell sub-
sets in the brain during the infection. The control and sub-
sequent resolution of neuroinflammation requires resident
immune cell activation and the persistent recruitment of
peripheral immune cells. Accordingly, we characterized
resident microglia and recruited immune cell populations.
Using hematopoietic cell marker CD45 and myeloid marker
CD11b, we distinguished the resident and recruited im-
mune cell populations via fluorescence-assisted cell sorting
(FACS), as described previously [23, 72]. In both non-in-
fected mice and mice infected with H. polygyrus only, the
prevailing immune cell population was the CD45loCD11b+
resident microglia, and the infiltration by peripheral CD45+
leukocytes was absent (Fig. 3a). In the brains of T. gondii-
infected and nematode co-infected mice, we observed an
infiltration of peripheral CD45hiCD11b− lymphocytes and
CD45hiCD11b+ myeloid cells along with a population of ac-
tivated microglia characterized by an increased expression
of CD45 (Fig. 3b).
To further characterize the immune cell recruitment
to the brain, we next assessed the abundance of Ly6C
monocyte subpopulations as a function of infection sta-
tus. Recruitment of Ly6C-positive cell populations
(Ly6Chi, Ly6Cint, and Ly6Clo) was affected by both T.
gondii (MANOVA with cell populations as dependent
variables and pathogens as fixed factor: F3, 11 = 162.9,
Wilks’ Λ = 0.022, p < 0.001) and, to a lesser extent, H.
polygyrus (F3, 11 = 3.82, Wilks’ Λ = 0.488, p = 0.042), and
there was a significant interaction between the two path-
ogens (F3, 11 = 3.88, Wilks’ Λ = 0.486, p = 0.041). While
T. gondii infection was associated with recruitment of all
three cell types (all F > 70.99, all p < 0.001), H. polygyrus
and its interaction with T. gondii selectively affected the
recruitment of Ly6Chi monocytes (all F > 10.28, all p <
0.007), but not Ly6Cint or Ly6Clo cells (all F > 0.95, all
p > 0.348). In direct comparisons, we found a signifi-
cantly higher proportion of Ly6Chi inflammatory mono-
cytes in the brains of co-infected mice compared to
animals solely infected with T. gondii (t5.9 = 3.35, p =
0.016; Fig. 3c), whereas no difference was detectable for
Ly6Cint or Ly6Clo mononuclear cells (all t < 1.07, all p >
0.320; Fig. 3c).
We next characterized the activation status of micro-
glia and recruited mononuclear cells by assessing their
expression status for the class II major histocompatibil-
ity complex (MHC II). Because of the very low MHC II
expression by microglia in uninfected mice and mice in-
fected with H. polygyrus only (Fig. 3d), we restricted stat-
istical analysis to co-infected mice and mice solely
infected with T. gondii. When testing for MHC II ex-
pression across cell populations (microglia, Ly6Chi,
Ly6Cint, and Ly6Clo), we found a significant increase in
MHC II expression in Ly6Chi mononuclear cells (MAN-
OVA with infection status as fixed factor: F4, 3 = 9.85,
Wilks’ Λ = 0.071, p = 0.045; post hoc t test: t3.6 = 5.82,
p = 0.006) and a trend-wise increase of MHC II expres-
sion in microglia (t5.5 = 2.12, p = 0.041, one-tailed; see
Fig. 3d, e) of the co-infected mice, whereas no robust
differences were evident for Ly6Cint or Ly6Clo cells (all
t < 1.78, all p > 0.065, one-tailed).
Given the importance of the Th1 response in the control
of a T. gondii infection and the observed reduction of
brain parasite burden (see above), we next compared the
expression of Th1 response-related genes (IL-12, TNF,
iNOS, and IL-10) in recruited mononuclear cells of co-in-
fected animals versus animals infected with T. gondii only.
When comparing the percentages of cytokine-producing
cells (Fig. 3f, h, j, and l) across cell types (microglia,
Ly6Chi, Ly6Cint, and Ly6Clo), we found a significant
modulation of cytokine levels as a function of cell type,
Fig. 2 Parasite burden decreases and worm fecundity increases upon H. polygyrus co-infection. a–c T. gondii parasite burden in the brains of T.
gondii infected (Tg) and T. gondii and H. polygyrus co-infected (Tg+Hp) mice. qPCR and qRT-PCR data of relative expression of T. gondii genes
TgB1 (a), Sag1 (b), and Bag1 (c), normalized to the T. gondii infected (Tg) group. d H. polygyrus worm burden. e Fecundity of female worms. Bars
represent mean ± SEM
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infection status, and gene as well as a significant inter-
action of cell type and infection status and a three-way
interaction cell type by gene by infection status (three-way
ANOVA for repeated measures with gene and cell type as
within-subjects factors and infection status as between-
subject factor: all F > 12.70, all p < 0.009; Greenhouse-
Geisser correction applied). These effects could be
attributed to co-infected animals showing higher propor-
tions of IL-12-positive cells across all cell types (post hoc
two-sample t tests: all t > 3.29, all p < 0.013) and slightly
higher proportions of iNOS-expressing Ly6C cells (all t >
2.29, all p < 0.058, one-tailed), but not microglia (t3.9 =
1.16, p = 0.182, one-tailed). When testing for mean fluor-
escence intensity (Fig. 3g, i, k, and m), a similar pattern
emerged with main effects of cell type, gene, and infection
status as well as significant interactions of cell type and in-
fection status, cell type and gene, and gene and infection
status (all F > 5.37, all p < 0.039; Greenhouse-Geisser
Fig. 3 Increased recruitment, MHC II, iNOS, and IL-12 expression in the brain upon H. polygyrus co-infection. Immune cells were isolated from the
brains non-infected (Non.Inf.), T. gondii-infected (Tg), T. gondii and H. polygyrus co-infected (Tg+Hp), and H. polygyrus-infected (Hp) mice and
analyzed by flow cytometry. a, b Representative gating strategy for immune cells. Following viability staining and the basic FSC/SSC gating, single
cells were chosen for further characterization. a CD11b+CD45int cells were identified as microglia. b In Tg-infected mice, myeloid cells
(CD11b+CD45hi) were further divided into neutrophils (Ly6G+CD11b+) and mononuclear cells (Ly6G−CD11b+). Ly6G−Ly6C+ mononuclear cells
were again divided into three subpopulations (Ly6Chi, Ly6Cint, and Ly6Clo). c Monocyte recruitment was calculated as a percentage of single cells
found in the brain. d, e Immune cell expression of MHC II was quantified using the MFI of their respective fluorochrome. f–m Immune cells were
further characterized by their intracellular expression of the proteins iNOS, IL-10, IL12, and TNF. Bar graphs represent the percentage of cells
positive for the marker of the respective population and the MFI of their respective fluorochrome. Bars represent mean ± SEM
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correction applied), plus a trend-wise three-way inter-
action (all F > 3.17, p = 0.063; Greenhouse-Geisser correc-
tion applied). These effects could be attributed to
increased expression of IL-12 in all cell types of co-
infected animals compared to animals infected with T.
gondii only (post hoc two-sample t tests: all t > 2.46, all
p < 0.026, one-tailed) and to all three mononuclear cell
subsets (Ly6Chi, Ly6Cint, and Ly6Clo) showing a higher ex-
pression of iNOS in co-infected animals (all t > 2.38, all
p < 0.027, one-tailed) when compared to only T. gondii-
only infected mice. Additionally, co-infected animals
showed higher expression levels of TNF in Ly6Cint and
Ly6Clo monocytes (all t > 2.61, all p < 0.049) and, as a
trend, in microglia (t4.9 = 2.01, p = 0.047, one-tailed). IL-10
levels were not affected by H. polygyrus in any cell popula-
tion (all t < 1.13, all p > 0.157, one-tailed).
The major role of IL-12 in chronic T. gondii infec-
tion is sustaining IFN-γ production [69]. Thus, we ex-
amined how T cell subsets (the primary IFN-γ
producers in chronic infection) are affected by co-in-
fection. CD45+CD11b− lymphocytes were further
gated for T cells based on CD3 expression and subse-
quently separated into CD4+ and CD8α+ populations
(Fig. 4a). The recruitment of CD4+ or CD8α+ T cells
to the brain was unchanged in T. gondii-infected and
co-infected mice (MANOVA with cell type as
dependent variable and infection status as fixed fac-
tor: F2, 7 = 2.65, Wilks’ Λ = 0.569, p = 0.139; Fig. 4c).
There was, however, a pronounced increase in the per-
centage of both CD3+CD4+ and CD3+CD8α+ T cells that
were positive for IFN-γ and TNF in co-infected compared
to T. gondii-infected animals (main effect of infection sta-
tus: F1, 8 = 43.52, p < 0.001; three-way ANOVA for re-
peated measures with cell type and cytokine as within-
subjects factors and infection status as between-subjects
factor; post hoc two-sample t tests: all t > 4.13, all p <
0.007; Fig. 4d and e). When comparing mean fluorescence
intensities, a three-way ANOVA for repeated measures
with cell type and cytokine as within-subjects factors and
infection status as between-subjects factor revealed a
highly significant three-way interaction of cell type, cyto-
kine, and infection status (F1, 8 = 15.54, p = 0.004), reflect-
ing an increased expression of IFN-γ in CD4+
lymphocytes (post hoc two-sample t test: t4.3 = 2.31, p =
0.036, one-tailed), while no further significant differences
were observed (all t < 0.916, all p > 0.197, one-tailed).
Taken together, these results indicate that T. gondii co-in-
fection with an acute H. polygyrus infection strongly in-
creases the proportion of IFN-γ-producing T cells in T.
gondii-infected mice.
Fig. 4 Increased type 1 response in T cells in the brain upon co-infection with H. polygyrus. Immune cells were isolated from the brains of T.
gondii-infected and T. gondii and H. polygyrus co-infected mice and analyzed by flow cytometry. a, b Representative gating strategy for
lymphocyte populations. Following a viability staining and FSC/SSC gating, single cells were chosen for further characterization. a In both non-
infected and H. polygyrus-infected mice, there was an absence of recruited CD45+ leukocytes. b In both Tg-infected and Tg and Hp co-infected
mice, CD11b−CD45hi cells were identified as lymphocytes and then further gated for CD3 expression. CD3+ lymphocytes were additionally gated
for CD4+ and CD8α+ T cells. c Lymphocyte recruitment was calculated as a percentage of single cells found in the brain. d, e Intracellular
expression of proteins in T cells was characterized by the percentage of cells positive for IFN-γ or TNF and the MFI of the positive cells of each
respective marker. Bars represent mean ± SEM
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Acute H. polygyrus co-infection enhances the T. gondii
infection-induced decrease of synaptic gene expression
Guided by previous observation that T. gondii-in-
duced neuroinflammation affects the synaptic protein
composition [35], and particularly glutamatergic
neurotransmission [34, 73], we next set out to inves-
tigate if the enhanced Th1 response influenced the
gene expression of synaptic markers in co-infected
mice. We focused our analyses on the pre-synaptic
vesicle protein synaptophysin (Syp), the post-synaptic
scaffolding protein PSD-95 encoded by the Dlg4
gene, the glutamate transporter EAAT2 encoded by
the Slc1a2 gene, and the α1 subunit of the GABA-A
receptor (GABAAα1) encoded by the Gabra1 gene as
well as the brain-derived neurotrophic factor
(BDNF), given its key role in synaptic plasticity and
learning [74, 75]. Expression levels were strongly af-
fected by T. gondii (three-way ANOVA for repeated
measures with expressed gene as within-subjects fac-
tor and T. gondii and H. polygyrus as between-sub-
jects factors; main effect: F1, 13 = 193.87, p < 0.001;
interaction with gene: F1.2, 15.1 = 166.34, p < 0.001)
and to a lesser, but significant extent, by H. poly-
gyrus (main effect: F1, 13 = 6.68, p = 0.023; interaction
with gene: F1.2, 15.1 = 6.26, p = 0.038), whereas no for-
mal interactions between the pathogens were ob-
served (all F < 2.00, all p > 0.208). All genes
investigated were markedly reduced in mice infected
with T. gondii compared to uninfected mice (post
hoc two-sample t tests: all t > 4.98, all p < 0.002;
Fig. 5a–e), in line with our previous proteomics
study [35]. Co-infection aggravated this pattern, as
expression of EAAT2 and GABAAα1 was signifi-
cantly lower in co-infected mice compared to mice
infected with T. gondii only (EAAT2: t4.3 = 2.90, p =
0.041; GABAAα1: t5.1 = 2.56, p = 0.050; Fig. 5d, e).
When compared to uninfected mice, mice infected
with H. polygyrus alone showed reduced expression
levels of GABAAα1 (t4.4 = 3.75, p = 0.017) and BDNF
(t4.3 = 4.32, p = 0.011; Fig. 5c, e). Collectively, these
data suggest that an acute nematode co-infection
amplifies the decrease of synaptic protein gene ex-
pression induced by T. gondii, possibly by exerting
an additive effect via systemic inflammatory activity.
Sulfadiazine reduces inflammation and attenuates loss of
synaptic gene expression
We next treated mice with sulfadiazine, which targets
the fast-replicating tachyzoite stages of infection and as
a consequence markedly reduces the strength of the
Th1 inflammatory response [76]. To assess if sulfadia-
zine treatment could indeed reduce T. gondii-induced
neuroinflammation, we investigated how pro-inflamma-
tory cytokine gene expression was affected. When
comparing expression levels of inflammation-related
genes in T. gondii-infected and co-infected mice
treated with sulfadiazine to those in untreated animals,
we observed significant effects of H. polygyrus infection
(main effect: F1, 13 = 16.94, p = 0.001; three-way
ANOVA for repeated measures with gene as within-
subjects factor and H. polygyrus infection and sulfadia-
zine treatment as between-subjects factors) and treat-
ment (main effect: F1, 13 = 82.73, p < 0.001), but only a
trend-wise interaction. Animals infected with T. gondii
alone showed a treatment-related reduction of gene ex-
pression for IFN-γ, iNOS, IL-1β, IL-10, and Arg1 (post
hoc two-sample t tests: all t > 4.61, all p < 0.008; Fig. 6a,
c–f ). When comparing untreated co-infected mice to
co-infected mice treated with sulfadiazine, the same
genes showed significantly reduced expression, and
there was additionally a significant reduction of IL-12
gene expression (all t > 3.22, all p < 0.036; Fig. 6a–f ).
To assess whether a reduced neuroinflammatory
response in sulfadiazine-treated animals would be as-
sociated with an attenuation of the synaptic alter-
ations, we next examined the effects of sulfadiazine
treatment on the reduction of synaptic marker gene
expression. As expected, we observed effects of T.
gondii infection (four-way ANOVA for repeated
measures with gene as within-subjects factor and T.
Fig. 5 Impairment of synaptic gene expression in the brain upon co-infection with H. polygyrus. a–e qRT-PCR data for relative expression of
mRNA in whole brain homogenate from non-infected (Non.Inf.), T. gondii-infected (Tg), T. gondii and H. polygyrus co-infected (Tg+Hp), and H.
polygyrus-infected (Hp) mice. Relative mRNA levels were normalized to the mean of the non-infected control group (Non.Inf). Bars
represent mean ± SEM
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gondii, H. polygyrus, and sulfadiazine treatment as be-
tween-subjects; main effect: F1, 23 = 55.09, p < 0.001;
interaction with gene: F1.4, 33.0 = 30.54, p < 0.001) and
co-infection (interaction T. gondii * H. polygyrus: F1,
23 = 6.14, p = 0.021; interaction with gene: F1.4, 33.0 =
3.97, p = 0.041). More importantly, there was a signifi-
cant interaction between T. gondii infection and sulfa-
diazine treatment (F1, 23 = 11.70, p = 0.002; interaction
with gene: F1.4, 33.0 = 6.68, p = 0.008) and a trend-wise
three-way interaction (T. gondii * H. polygyrus * treat-
ment: F1, 23 = 3.53, p = 0.073). Compared to untreated
animals, T. gondii-infected mice treated with sulfadia-
zine to infected showed a significantly higher expres-
sion of EAAT2 (post hoc two-sample t test: t6.0 =
8.82, p < 0.001) and BDNF (t3.1 = 4.91, p = 0.015). In
co-infected mice, the attenuation of synaptic gene ex-
pression loss by sulfadiazine treatment was even more
pronounced with all genes examined except PSD-95
showing significantly higher expression levels in
treated animals (all t > 3.26, all p < 0.035). On the
other hand, sulfadiazine treatment did not signifi-
cantly affect the synaptic gene expression in mice
infected with H. polygyrus only or in non-infected
mice (all t < 1.47, all p > 0.192), thus excluding unspe-
cific effects of sulfadiazine on gene expression of syn-
aptic proteins (Fig. 7a–e). Taken together, these
results suggest that sulfadiazine treatment successfully
reduced the strength of the T. gondii infection-
Fig. 6 Sulfadiazine treatment reduces the gene expression of pro-inflammatory mediators upon T. gondii infection. RNA was isolated from whole
brain homogenate of T. gondii-infected and co-infected mice with or without sulfadiazine treatment. (a–f) qRT-PCR data for relative expression of
mRNA in whole brain homogenate from T. gondii-infected (Tg), T. gondii and H. polygyrus co-infected (Tg+Hp), T. gondii-infected and sulfadiazine-
treated (Tg + Sulfa), and T. gondii and H. polygyrus co-infected and sulfadiazine treated (TgHp + Sulfa) mice. Relative mRNA levels were
normalized to the mean of the T. gondii-infected group. Bars represent mean±SEM
Fig. 7 Sulfadiazine treatment prevents T. gondii infection-induced decrease of synapse-related gene expression. Non-infected, T. gondii-infected, H.
polygyrus-infected, and co-infected mice were treated with sulfadiazine, and RNA isolated from whole brain homogenate were isolated. a–e qRT-
PCR data for relative expression of mRNA from non-infected (Non.Inf.), non-infected + sulfadiazine treatment (Non.Inf.+sulfa), T. gondii-infected
(Tg), T. gondii-infected + sulfadiazine treatment (Tg+sulfa), T. gondii and H. polygyrus co-infected (Tg+Hp), T. gondii and H. polygyrus co-infected +
sulfadiazine treatment (Tg+Hp+sulfa), H. polygyrus-infected (Hp), and H. polygyrus-infected + sulfadiazine treatment (Hp+sulfa) mice. Relative
mRNA levels were normalized to the mean of the non-infected control group (Non.Inf.). Bars represent mean±SEM
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induced neuroinflammation, thereby attenuating
changes to synaptic gene expression.
IFN-γ neutralization inhibits antiparasitic response and
partly recovers synaptic gene expression
Considering the key role of IFN-γ in the antiparasitic
response and its previously described effects on
GABAergic signaling [6], along with the reduction in
EAAT2 and GABAAα1 mRNA expression observed
here, we hypothesized that neutralizing IFN-γ would
rescue the loss of synaptic gene expression described
above. When co-infected mice were treated with IFN-
γ-neutralizing antibodies, gene expression of synaptic
proteins was significantly changed compared to un-
treated co-infected animals (main effect of αIFN-γ
treatment: F1, 8 = 13.60, p = 0.006; interaction treat-
ment by gene: F1.2, 9.4 = 12.10, p = 0.005; two-way
ANOVA for repeated measures with gene as within-
subjects factor and treatment as between-subjects fac-
tor). Specifically, IFN-γ-neutralized animals exhibited
significant gene expression level changes for Syp,
PSD-95, and EAAT2 (post hoc two-sample t tests: all
t > 2.47, all p < 0.040) as well as a trend-wise rescue of
GABAAα1 expression (t4.2 = 2.70, p = 0.026, one-tailed)
(Fig. 8a, b, d, e), whereas BDNF showed no difference
in gene transcription as a function of αIFN-γ treat-
ment (Fig. 8c).
We next examined how αIFN-γ treatment affected
the parasite burden of the co-infected mice. We
found the specific antigens of both tachyzoites and
bradyzoites to be significantly increased in IFN-γ-neu-
tralized mice when compared to untreated co-infected
animals (Tgbag1: t5.0 = 4.51, p = 0.006; Tgsag1: t5.4 =
5.37, p = 0.002, Fig. 8j, k). As a reduced parasite load
could thus not explain the rescue of synaptic gene ex-
pression, we next aimed to elucidate if neurotoxic or
phagocytic immune cell activity might be involved in
the altered synaptic gene expression. To assess poten-
tially increased cytotoxic activity, we examined ex-
pression of iNOS in αIFN-γ-treated compared to
Fig. 8 IFN-γ neutralization partially prevents synaptic gene expression, decreases iNOS, CD36, TREM2, C1qa expression and enhances parasite
burden in the CNS. Co-infected mice were treated with 0.5 mg of anti-IFN-γ or IgG1 at days 14, 17, 20, 23, and 26 post-infection. a–k qRT-PCR
data for relative expression of mRNA in brain cortex homogenate from non-infected (Non.Inf.), T. gondii-infected (Tg), T. gondii and H. polygyrus
co-infected with IgG1 injection (Tg+Hp), T. gondii and H. polygyrus co-infected with IFN-γ neutralization (αIFN-γ), and H. polygyrus-infected (Hp)
mice. Relative mRNA levels were normalized to the mean of the non-infected control group (Non.Inf). Bars represent mean ± SEM
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untreated animals. Indeed, iNOS expression decreased
as a function of IFN-γ antagonization (t4.7 = 3.34, p =
0.022). We next aimed to test whether phagocytic ac-
tivity might be affected by αIFN-γ treatment and thus
examined gene expression of CD36 and TREM2
(markers involved in phagocytosis, parasite killing,
scavenging, and synaptic pruning) in treated com-
pared to untreated animals. Both markers were sig-
nificantly reduced in αIFN-γ-treated compared to
untreated co-infected mice (two-way ANOVA for re-
peated measures with gene as within-subjects factor
and αIFN-γ treatment as between-subjects factor:
main effect: F1, 8 = 18.04, p = 0.002; interaction: F1, 8 =
6.43, p = 0.035; post hoc two-sample t tests: CD36:
t7.1 = 5.08, p = 0.001; TREM2: t4.1 = 3.42, p = 0.025)
(Fig. 8f–i), suggesting a role for phagocytosis and syn-
aptic pruning in the reduced synaptic gene expres-
sion. As phagocytosis is typically promoted by
activation of the complement system, we further
tested for C1qa expression in treated and untreated
mice and observed a small but significant reduction
of C1qa mRNA expression upon αIFN-γ treatment
(t8.0 = 2.33, p = 0.048).
Discussion
In this study, we investigated if T. gondii infection-in-
duced chronic neuroinflammation can be modulated
by a consecutive intestinal infection with H. polygyrus.
Our findings suggest that an acute nematode infection
resulted in enhanced T. gondii removal, though at the
same time exacerbated the inflammation-related de-
crease of gene expression of synapse-associated
proteins.
Co-infection of T. gondii-infected mice with H. poly-
gyrus was associated with a significant increase of the
Th1-type response, whereas the IL-4 associated Th2
response was comparably suppressed in the brains of co-
infected mice. The positive effect of IL-4 in the generation
of Th1-mediated immunity in the periphery has been
previously acknowledged [77, 78]. The reason for this
regulation is that CD8 T cell-derived IL-4 is responsible
for maturation of dendritic cells that in turn accelerate
Th1 immune responses [79]. Previous studies have shown
that H. polygyrus infection was able to impede the T. gon-
dii-associated Th1 response; however, in those experi-
ments, the nematode was applied prior to T. gondii
infection [60, 80]. Moreover, we have previously reported
that co-infection of mice with T. gondii and a nematode
did not alter the course of Th1 infection in the gut, but
we had used a high dose of T. gondii to induce ileitis and
mice succumbed in the acute phase of the infection [81].
We have recently reported, using a similar experimental
setup, that polarization of peripheral CD4+ T cells was
disturbed in mice previously infected with T. gondii and
later co-infected with H. polygyrus [82]. Of note, T. gondii
infection did not prevent H. polygyrus-specific priming of
T cells, but only the polarization to a Th2 phenotype, as
H. polygyrus-reactive CD4+ T cells upregulated T-bet ex-
pression (a Th1 transcription factor that controls IFN-γ
expression) and IFN-γ production. The T cells that specif-
ically recognized H. polygyrus antigens nevertheless
responded in a similar way as Th1 T. gondii-specific CD4+
T cells [82]. This may explain the reduction of parasite
burden and increase in nematode fecundity in the co-in-
fected animals. Immune cells responding to H. polygyrus,
continuously present in the intestine, exhibit Th1 effector
functions and further direct circulating immune cells to-
wards a Th1 fate. Our current results align with this hy-
pothesis. We found recruited CD4+, CD8+, and
mononuclear cells with significant increases of the propor-
tion of cells exhibiting Th1 effector function as deter-
mined by IFN-γ, iNOS, and IL-12 expression. In line with
our results, T cells exhibiting a plastic Th1/Th2 shift have
also been shown in a helminth/plasmodium co-infection
model [64]. H. polygyrus-primed cells adoptively trans-
ferred into Plasmodium chabaudi-infected animals were
converted to IFN-γ-producing cells and subsequently
decreased in parasitemia. Future studies should investigate
which immune cells mediate the decrease in parasite
burden and whether they are T. gondii or H. polygyrus-
specific.
Under homeostatic conditions, distinct cytokines exert a
fine-tuned modulatory influence on learning, memory, and
synaptic transmission in the CNS. During an infection,
increased production of pro-inflammatory cytokines can
disrupt the balance of neuro-immune interactions and lead
to detrimental effects on neural plasticity and memory as
well as neurogenesis and neuronal survival [83]. Pathologic-
ally increased levels of IL-1β and TNF can induce degener-
ation of neurons, alter synaptic scaling, and lead to
hyperexcitability, which impairs motor and cognitive per-
formance [7, 8, 84]. Along the same line, nitric oxide (NO)
released from activated microglia via iNOS inhibits neur-
onal respiration that results in glutamate release, the princi-
pal excitatory neurotransmitter [85]. NO can also block the
presynaptic reuptake of glutamate [86, 87] thereby leading
to excitotoxicity and ultimately neurodegeneration. Consist-
ently, in our present setting, co-infected mice exhibited a
significant increase of microglia, myeloid cells, and T cells
producing iNOS, IL-12, TNF, and IFN-γ, as well as an in-
crease in gene expression of pro-inflammatory proteins
IFN-γ, TNF IL-6, IL-1β, and iNOS. Previous studies have
convergingly shown that T. gondii infection-induced
neuroinflammation is associated with markedly reduced
expression of key synaptic proteins, including EAAT2,
PSD-95, or Shank3 [34, 35], which may lead to increased
extracellular glutamate levels and resulting excitotoxicity
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[73]. Correspondingly, in the present study, both T. gondii-
infected and co-infected mice displayed a significant
decrease in gene expression of synaptic markers synapto-
physin, PSD-95, BDNF, EAAT2, and GABAAα1. Notably,
expression of glutamate transporter EAAT2 and GABA-A
receptor subunit GABAAα1 were further significantly re-
duced in co-infected mice compared to mice infected with
T. gondii only. With EAAT2 being critical for clearance of
extracellular glutamate from the synaptic cleft and
GABAAα1 being a key component of inhibitory GABAergic
signaling, their conjoint downregulation is likely to shift the
delicate excitation-inhibition balance towards excitation,
thereby promoting excitotoxicity (see also [73]). Of note, it
is difficult to deduce the loss of synaptic integrity from gene
expression alone. For example, Brooks et al. described
altered GABAergic signaling in T. gondii infection [88].
Specifically, they found that the infection led to a loss of
synaptic clustering of the GABA-synthesizing enzyme glu-
tamate decarboxylase 67 (GAD67) in infected animals,
resulting in a more diffuse localization throughout the
neuropil. Changes in synaptic protein function were not
always reflected by altered gene expression. We have previ-
ously reported a more detailed record of T. gondii-related
changes of synaptic biochemistry at the protein level [35],
and the present results add to those observations by dem-
onstrating an aggravating effect on synaptic alterations by
an acute inflammation induced by the nematode co-infec-
tion. There was an exacerbation of neuroinflammation
upon co-infection that reduced gene expression of synaptic
proteins further compared to animals infected with T.
gondii only, potentially leaving mice more prone to excito-
toxicity and neurodegenerative states.
To test whether the observed changes in neuronal
gene expression were induced by the T. gondii-induced
inflammatory milieu, we treated mice with sulfadiazine,
which eliminates extracellular parasites, thus indirectly
alleviating inflammatory responses [35]. Remarkably, the
resulting reduction of neuroinflammation was associated
with an attenuated decrease in gene expression of synap-
tic-associated proteins, supporting the hypothesis that
the inflammatory response is responsible for the neur-
onal alterations.
Given the increased gene expression of IFN-γ in in-
fected animals and its functions in the immune
response to T. gondii, we hypothesized that antagon-
izing IFN-γ signaling would help to clarify the cause
of the changes in gene expression of synapse-associ-
ated proteins. Consistent with the hypothesis that the
specific inflammatory milieu was responsible for re-
duced synaptic gene expression, neutralizing IFN-γ re-
sulted in a partial rescue of the synaptic gene
expression loss. The gene expression levels of synaptic
proteins previously shown to be downregulated in T.
gondii-infected animals, such as EAAT2 and
GABAAα1 [73, 88], were significantly higher when an-
imals were treated with an antibody directed against
IFN-γ. It was recently demonstrated that priming of
microglia with IFN-γ induced activation, MHC II up-
regulation, followed concomitant iNOS production
responsible for neuronal network dysfunction involv-
ing inhibitory interneurons [89]. In our experiments
we also detected IFN-γ associated MHC II, iNOS,
and IL-12 upregulation in isolated microglia cells and
in recruited monocytes. Moreover, increased expres-
sion of EAAT2 and GABAAα1, as key components in
the excitation/inhibition balance, was associated with
reduced IFN-γ and iNOS levels pointing towards a
possible mechanism for their regulation.
To further elucidate the underlying molecular
mechanisms that might be responsible for the im-
mune response-related neuronal alterations, we fo-
cused on cells with phagocytic capacity. Under
normal homeostatic conditions, microglia have been
shown to engulf neural progenitor cells and synapses.
This phagocytic activity is often induced upon release
of intracellular molecules (e.g., ATP) or tagging via
the complement system [5]. Microglial-mediated
phagocytosis of synapses depends on surface receptors
recognizing their ligand. Triggering receptor
expressed on myeloid cells 2 (TREM2) is a microglial
receptor that mediates phagocytosis apoptotic cell
debris and developmental synaptic pruning [90]. Simi-
larly, CD36, a scavenger receptor on microglia and in-
filtrating monocytes, will recognize host and
pathogen-derived molecules leading to upregulation of
inflammatory molecules (i.e., iNOS and Nox-2) [91].
Both CD36 and TREM2 are understood to be neuro-
protective; however, in pathological conditions like
neuroinflammation, these have been associated with
neurodegenerative diseases such as AD [65, 92, 93].
Therefore, we characterized gene expression of phago-
cytic markers associated with synaptic pruning such
as CD36, TREM2, and C1qa. Our results showed a
significant increase in pro-inflammatory cytokine pro-
duction indicative of prolonged CNS neuro-immune
activity. Furthermore, we observed a significant reduc-
tion of CD36, TREM2, and C1qa upon IFN-γ
neutralization in co-infected mice, suggesting pro-
longed presence of activated phagocytes and pro-in-
flammatory cytokines is contributing to the loss of
synaptic gene expression. Future studies should
dissect the involvement and phagocytic capacity of
resident and recruited immune cells that alter synap-
ses. It should be noted that mice in complete lack of
IFN-γ rapidly succumb to T. gondii infection [28, 94],
and we thus reduced IFN-γ levels only partially when
applying the neutralizing antibody. Accordingly, the
reduction of CD36, TREM2, and C1qa expression was
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also incomplete with the genes still being expressed,
albeit at significantly lower levels. Therefore, we can-
not conclusively state whether the partial recovery of
synaptic gene expression in T. gondii-infected and co-
infected mice treated with the IFN-γ antibody was
due to inflammatory activity induced by remaining
low levels of IFN-γ, due to other proinflammatory cy-
tokines, or due to definite effects of the parasite itself.
Thus, subtle alterations of neural function induced by
prolonged low-grade inflammation should not be
ignored. Even post-pathogen elimination, adverse ef-
fects induced by neuroinflammation may manifest as
neuronal and behavioral alterations or cognitive im-
pairment [95–99]. Accordingly, it is likely that mul-
tiple mechanisms are involved in synaptic gene
expression changes; nevertheless, the critical involve-
ment of IFN-γ was revealed.
Conclusion
Taken together, our data suggest that a neuroinflam-
matory response to T. gondii can be modulated by a
strictly enteric helminth co-infection. While consecu-
tive H. polygyrus co-infection promoted elimination of
T. gondii, it adversely affected neural function and
synapse-associated gene expression in an IFN-γ-
dependent fashion. Helminth immunotherapy has to
some extent proven to be successful in chronic in-
flammatory diseases such as autoimmune disorders or
allergies [44, 46, 54, 55]. Regarding potential clinical
implications, T. gondii seropositive individuals may be
at risk for developing neuropsychiatric disorders [18,
100–102]; thus, future research should assess to what
extent this risk may be further aggravated by manipu-
lation of the peripheral inflammation [83].
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